{
    "clinical_study": {
        "@rank": "31734", 
        "acronym": "METEORR", 
        "arm_group": {
            "arm_group_label": "Register R", 
            "arm_group_type": "Other", 
            "description": "Evaluation of erectile dysfunction in the management of localized rectal cancer"
        }, 
        "brief_summary": {
            "textblock": "Erectile dysfunction will be explored by recording R / P and self-administered questionnaire\n      IIEF-5."
        }, 
        "brief_title": "Erectile Rating During the Treatment of Rectal Cancers Localized", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rectal Cancer Stage I", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Erectile dysfunction will be explored by recording R / P and self-administered questionnaire\n      IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment\n      and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24\n      months after surgery. There will be no changes made \u200b\u200bto support oncology patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male patient.\n\n          2. Age greater than 18 years.\n\n          3. Neoplastic rectal stage \u2264 T3.\n\n          4. Patient sexually active before diagnosis.\n\n          5. Laparoscopic surgery.\n\n          6. Medico-surgical institute Bergoni\u00e9.\n\n          7. Patient information and consent for participation in the study.\n\n        Exclusion Criteria:\n\n          1. Patients already treated for erectile dysfunction.\n\n          2. Absence of sexual activity before diagnosis.\n\n          3. Presence of secondary lesions at diagnosis (M +).\n\n          4. Classified T4 tumor preoperatively.\n\n          5. Surgery by laparotomy.\n\n          6. History of pelvic cancer surgery prostate or bladder.\n\n          7. History of pelvic radiotherapy (outside of the current process).\n\n          8. History of prostate or bladder neoplasia known.\n\n          9. Other neoplastic known.\n\n         10. Patient for psychological, social, family or geographical could not be treated or\n             monitored regularly according to the criteria of the study, patient deprived of\n             liberty or under guardianship."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01843218", 
            "org_study_id": "IB2008-07"
        }, 
        "intervention": {
            "arm_group_label": "Register R", 
            "description": "Register R / P and self-administered questionnaire IIEF-5", 
            "intervention_name": "Evaluation of erectile dysfunction", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Localized rectal cancer in a male patient", 
        "lastchanged_date": "April 26, 2013", 
        "link": {
            "description": "Site internet du promoteur, l'Institut Bergoni\u00e9", 
            "url": "http://www.bergonie.org/fr/essais-clinique.html"
        }, 
        "location": {
            "contact": {
                "email": "s.evrard@bordeaux.unicancer.fr", 
                "last_name": "EVRARD SERGE, PU-PH"
            }, 
            "facility": {
                "address": {
                    "city": "Bordeaux", 
                    "country": "France", 
                    "state": "Aquitaine", 
                    "zip": "33000"
                }, 
                "name": "Institut Bergoni\u00e9"
            }, 
            "investigator": {
                "last_name": "EVRARD SERGE, PU-PH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study", 
        "overall_contact": {
            "email": "s.evrard@bordeaux.unicancer.fr", 
            "last_name": "EVRARD SERGE, PU-PH"
        }, 
        "overall_contact_backup": {
            "email": "s.mathoulin@bordeaux.unicancer.fr", 
            "last_name": "MATHOULIN PELISSIER Simone, PU-PH"
        }, 
        "overall_official": {
            "affiliation": "Institut Bergoni\u00e9", 
            "last_name": "EVRARD Serge, PU-PH", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate objectively the presence of erectile dysfunction induced by medico-surgical treatment of rectal cancer three months after surgery. These objective data will be obtained using the Rigiscan \u00ae PLUS system coupled to a polysomnogram. the investigators use the abbreviation Register R / P (Rigiscan \u00ae PLUS / polysomonographie) in this protocol.", 
            "measure": "assess erectile dysfunction", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01843218"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Describe objectively and qualitatively erectile dysfunction before and 3 and 12 months after the medico-surgical management.", 
            "measure": "Evaluate objectively the presence of erectile dysfunction before and 12 months after the medico-surgical treatment of rectal cancer", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "Institut Bergoni\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Bergoni\u00e9", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2008", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}